Aelis Farma
Clinical trials sponsored by Aelis Farma, explained in plain language.
A biopharmaceutical company focused on developing treatments for brain disorders.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
Down syndrome drug trial asks participants: how did it feel?
Knowledge-focused By invitation onlyThis study follows up on a previous trial of the drug AEF0217 in people with Down syndrome. Researchers are asking participants and their caregivers to share their impressions of the treatment through a simple questionnaire. The goal is to understand what changes, if any, people …
Sponsor: Aelis Farma • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Cannabis drug interaction study pulled before starting
Knowledge-focused CancelledThis study aimed to see if a drug called AEF0117 changes how the body processes THC from cannabis. It was designed for healthy adults aged 21-55 who use cannabis. The trial was withdrawn before enrolling anyone, so no results are available.
Phase 1 • Sponsor: Aelis Farma • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:09 UTC